{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:55:16Z","timestamp":1791255316305,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1053\/j.jvca.2013.10.004","type":"journal-article","created":{"date-parts":[[2014,1,18]],"date-time":"2014-01-18T20:00:17Z","timestamp":1390075217000},"page":"1013-1017","source":"Crossref","is-referenced-by-count":20,"title":["Anticoagulation for Critically Ill Cardiac Surgery Patients: Is Primary Bivalirudin the Next Step?"],"prefix":"10.1053","volume":"28","author":[{"given":"Federico","family":"Pappalardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliya","family":"Agracheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remo Daniel","family":"Covello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Pieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"De Bonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Koster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Zangrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2013.10.004_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1378\/chest.11-3074","article-title":"Clinical and biological features of patients suspected or confirmed to have heparin-induced thrombocytopenia in a cardiothoracic surgical ICU","volume":"142","author":"Trehel-Tursis","year":"2012","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2013.10.004_bib2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1213\/ANE.0b013e3182297031","article-title":"A diagnosis of heparin induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients","volume":"113","author":"Demma","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2013.10.004_bib3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ahj.2009.01.005","article-title":"Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications after Thrombocytopenia Caused by heparin (CATCH) registry","volume":"157","author":"Crespo","year":"2009","journal-title":"Am Heart J"},{"key":"10.1053\/j.jvca.2013.10.004_bib4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/j.jvca.2010.12.015","article-title":"Update in hematology: Heparin-induced thrombocytopenia and bivalirudin","volume":"25","author":"Augoustides","year":"2011","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2013.10.004_bib5","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.amjcard.2012.04.017","volume":"110","author":"Patti","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2013.10.004_bib6","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1056\/NEJMoa1109596","article-title":"ISAR-REACT 4 Trial Investigators. Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction","volume":"365","author":"Kastrati","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2013.10.004_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/CIRCINTERVENTIONS.111.961912","volume":"4","author":"Bangalore","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1053\/j.jvca.2013.10.004_bib8","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/ccd.23179","article-title":"Effect of bivalirudin compared with unfractionated heparin plus abciximab on infarct size and myocardial recovery after primary percutaneous coronary intervention: The horizons-AMI CMRI substudy","volume":"79","author":"W\u00f6hrle","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1053\/j.jvca.2013.10.004_bib9","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.amjcard.2004.01.033","article-title":"Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)","volume":"93","author":"Lincoff","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2013.10.004_bib10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jama.289.7.853","article-title":"Bivalirudin and provisional glycoprotein IIb\/IIIa blockade compared with heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial","volume":"289","author":"Lincoff","year":"2003","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2013.10.004_bib11","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.amjcard.2010.06.047","article-title":"Validation of long-term benefits of bivalirudin versus unfractionated heparin in routine clinical practice after percutaneous coronary intervention","volume":"106","author":"Vidi","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2013.10.004_bib12","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.ejcts.2009.12.023","article-title":"Perioperative thrombocytopenia in cardiac surgical patients\u2014Incidence of heparin-induced thrombocytopenia, morbidities and mortality","volume":"37","author":"Thielmann","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2013.10.004_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.jvca.2006.05.002","article-title":"Heparin-induced thrombocytopenia following cardiac surgery is associated with poor outcome","volume":"21","author":"Kuitunen","year":"2007","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2013.10.004_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1055\/s-0030-1250184","article-title":"Heparin-induced thrombocytopenia type II after cardiac surgery: Predictors and outcome","volume":"58","author":"Assman","year":"2010","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2013.10.004_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/0267659109106773","article-title":"Bioline heparin-coated ECMO with bivalirudin anticoagulation in a patient with acute heparin-induced thrombocytopenia: The immune reaction appeared to continue unabated","volume":"24","author":"Pappalardo","year":"2009","journal-title":"Perfusion"},{"key":"10.1053\/j.jvca.2013.10.004_bib16","doi-asserted-by":"crossref","first-page":"R275","DOI":"10.1186\/cc10556","article-title":"Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation","volume":"15","author":"Ranucci","year":"2011","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2013.10.004_bib17","first-page":"1633","article-title":"Heparin-induced thrombocytopenia in patients with ventricular assist devices: Are new prevention strategies required?","volume":"87","author":"Warkentin","year":"2009"},{"key":"10.1053\/j.jvca.2013.10.004_bib18","first-page":"330","article-title":"Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices","volume":"78","author":"Pappalardo","year":"2012","journal-title":"Minerva Anestesiol"},{"key":"10.1053\/j.jvca.2013.10.004_bib19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1538-7836.2009.03626.x","article-title":"Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive","volume":"8","author":"Selleng","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2013.10.004_bib20","doi-asserted-by":"crossref","first-page":"e495S","DOI":"10.1378\/chest.11-2303","article-title":"American College of Chest Physicians. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Linkins","year":"2012","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2013.10.004_bib21","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1055\/s-0038-1648515","article-title":"Heparin binding to plasma proteins, an important mechanism for heparin resistance","volume":"67","author":"Young","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.jvca.2013.10.004_bib22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0167-4889(85)90177-6","article-title":"Binding and endocytosis of heparin by human endothelial cells in culture","volume":"845","author":"Barzu","year":"1985","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.jvca.2013.10.004_bib23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/026765919901400606","article-title":"Predictors for heparin resistance in patients undergoing coronary artery bypass grafting","volume":"14","author":"Ranucci","year":"1999","journal-title":"Perfusion"},{"key":"10.1053\/j.jvca.2013.10.004_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.amjcard.2007.02.106","article-title":"Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin","volume":"100","author":"Anand","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2013.10.004_bib25","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1055\/s-0037-1616529","article-title":"Human thrombi contain an abundance of active thrombin","volume":"86","author":"Mutch","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.jvca.2013.10.004_bib26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI114723","article-title":"Clot bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors","volume":"86","author":"Weitz","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jvca.2013.10.004_bib27","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12630-010-9423-0","article-title":"Bivalirudin utilization in cardiac surgery: Shifting anticoagulation from indirect to direct thrombin inhibition","volume":"58","author":"Anand","year":"2011","journal-title":"Can J Anaesth"},{"key":"10.1053\/j.jvca.2013.10.004_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.jvca.2012.07.019","article-title":"Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: A case-control study","volume":"27","author":"Pieri","year":"2013","journal-title":"J Cardiothorac Vasc Anest"},{"key":"10.1053\/j.jvca.2013.10.004_bib29","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1177\/039139880602901205","article-title":"Autopsy findings in patients on postcardiotomy extracorporeal membrane oxygenation (ECMO)","volume":"29","author":"Rastan","year":"2006","journal-title":"Int J Artif Organs"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077013005284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077013005284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T16:19:19Z","timestamp":1565108359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077013005284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1053077013005284"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2013.10.004","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}